无菌复合药房市场增长、规模、份额、趋势、关键参与者分析及预测至 2028 年

  • Report Code : TIPRE00026302
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 163
Buy Now

 

[研究报告] 无菌复合药房市场预计将从 2021 年的 39.687 亿美元增至 2028 年的 61.9859 亿美元;预计 2021 年至 2028 年的复合年增长率为 6.6%。

个性化药物使用率的提高以及现场无菌配制带来的好处等因素推动了市场的增长。然而,产品召回和严格的监管要求阻碍了市场的增长。另一方面,在预测期内,集中或区域配制中心的开发将为市场增长创造丰厚的机会。

2021-2028 年,北美很可能继续在无菌复合药房市场占据主导地位。美国在北美市场占有最大份额,预计在预测期内将继续保持这一趋势。这主要归因于不断增长的医药支出和完善的医疗保健基础设施。例如,美国食品药品监督管理局 (FDA) 已指定 503B(根据记录,503B 被称为外包设施,有时被称为 503B 药房,并受到 FDA 的严格监控,从而建立了新的患者护理和安全水平)。此外,美国近 75% 的医院将无菌复合制剂外包给 503B 设施,以确保稳定性、应对药品短缺、获得即用型药品并延长保质期。此外,老年人口的增加和越来越多地采用定制配方而非商业产品,预计将在未来几年  推动美国无菌复合药房市场的增长。

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

无菌复合药房市场:

Sterile Compounding Pharmacies Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

市场洞察

 

现场无菌配制的优势推动市场增长

如果要根据患者的需求定制静脉注射液,现场配制和灭菌可能至关重要。现场制造允许在早期临床药物开发的起始阶段将活性药物成分(API) 引入人类受试者体内。无菌临时配制为按照良好生产规范 (GMP) 标准设计的昂贵且长期的肠外研究产品开发提供了一种灵活的选择。通常,用于临床研究的肠外给药 API 是在 GMP 条件下制造的。这可能会缩短生产特定剂量所需成品所需的时间。

此外,通过与药品申办方和临床现场药剂师的密切合作,可以成功地将配方配制并过滤成无菌静脉溶液,从而有效地进行无菌测试。

现场无菌配制在全球市场上引起了广泛关注,是推动市场增长的最重要因素之一。这是因为无菌配制药剂师更加关注最新的研究活动、创新技术、质量控制规则以及获取满足患者需求的最佳成分。例如,美国药房委员会协会 (NABP) 宣布获得美国食品药品管理局 (FDA) 的资助,以开发一个数据共享系统,以加强对无菌配制药房的监督。预计这一新系统将有助于收集、管理和共享与美国无菌配制相关的信息。该项目还旨在降低受伤风险,使患者免受配制不当的药品的侵害。

 

基于产品的洞察

根据产品,无菌复合药房市场分为注射药物和输液。注射药物部分将在 2021-2028 年期间占据更大的市场份额。注射药物因其更快的作用方式而成为备受青睐的无菌复合产品之一。为了避免对患者产生任何不利影响,复合注射药物(定义为在办公室稀释、混合、重构和制备的药物)是在这样的环境中复合的,在这种环境中,可以采取适当的保护措施防止疾病传播,并且复合药物的成分具有适当的强度和组成。市场参与者正在采用有机和无机增长战略来实现市场增长。例如,2019 年 9 月,QuVa Pharma, Inc. 宣布复合无菌注射制剂的产能大幅增加。

 

 

无菌复合药房市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响无菌复合药房市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的无菌复合药房市场细分和地理位置。

Sterile Compounding Pharmacies Market
  • 获取无菌复合药房市场的区域特定数据

无菌复合药房市场报告范围

报告属性细节
2021 年市场规模39.7亿美元
2028 年市场规模62亿美元
全球复合年增长率(2021 - 2028)6.6%
史料2019-2020
预测期2022-2028
涵盖的领域按产品
  • 注射药物和输液
按给药途径
  • 静脉
  • 肌肉注射
  • 皮下
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 法格隆公司
  • 三角复合药房
  • B. Braun Melsungen AG
  • PharMedium Healthcare Holdings, Inc.
  • 弗雷森卡比公司
  • Avella 专业药房
  • Pencol 复合药房
  • Pavilion Compounding Pharmacy,LLC。
  • 佩斯药房

 

无菌复合药房市场参与者密度:了解其对业务动态的影响

由于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素,终端用户需求不断增加,无菌复合药房市场正在快速增长。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在无菌复合药房市场运营的主要公司有:

  1. 法格隆公司
  2. 三角复合药房
  3. B. Braun Melsungen AG
  4. PharMedium Healthcare Holdings, Inc.
  5. 弗雷森卡比公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Sterile Compounding Pharmacies Market

 

  • 获取无菌复合药房市场顶级关键参与者概述

 

基于给药途径的见解

根据给药途径,无菌复合药房市场细分为静脉注射、肌肉注射和皮下注射。静脉注射部分在 2020 年占据了最大的市场份额,预计在预测期内将继续占据主导地位。然而,肌肉注射部分预计在预测期内在市场上的复合年增长率最高。肌肉注射 (IM) 途径给药是最常见的肠外注射途径。许多抗生素、术前镇静剂和麻醉剂都是通过肌肉注射途径给药的。例如,2021 年 2 月,Biogen 宣布美国食品和药物管理局 (FDA) 批准了一种新的肌肉注射 (IM) 注射剂“Plegridy (聚乙二醇干扰素β-1a)”,用于治疗多发性硬化症 (MS)。

在无菌复合药房市场运营的公司采用产品创新战略来满足世界各地不断变化的客户需求,这也使他们能够在全球市场上保持自己的品牌名称。

根据产品,无菌配制药房市场分为注射剂和输液剂。

根据给药途径,无菌配制药房市场细分为静脉注射、肌肉注射和皮下注射

 

无菌配药药房市场规模 – 按地区划分

  • 北美
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • MEA 其他地区
  • 南美洲和中美洲(SCAM)
    • 巴西
    • 阿根廷
    • 其余的骗局

 


公司简介

  • 法格隆公司
  • 三角复合药房
  • B. Braun Melsungen AG
  • PharMedium Healthcare Holdings, Inc.
  • 费森尤斯卡比公司
  • Avella 专业药房
  • Pencol 复合药房
  • 亭阁复合药房有限公司
  • 佩斯药房
  • 金沙集团
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the sterile compounding pharmacies market across the globe?

Rising uptake of personalized medicines and the benefits of on-sterile compounding are the most significant factors responsible for the overall market growth.

Which segment led the sterile compounding pharmacies market?

Based on product type, injectable drugs took the forefront lead in the worldwide market by accounting largest share in 2020 and is expected to continue to do so till the forecast period.

Which route of administration segment held the largest revenue (US$ Mn) in the sterile compounding pharmacies market?

The intravenous segment dominated the global sterile compounding pharmacies market and accounted for the largest revenue of 2,954.51 Mn in 2021.

What is meant by the sterile compounding pharmacies market?

Sterile compounding pharmacies involve creating a medication in an environment free from viruses, bacteria, or any other potentially infectious microorganisms. Such a type of compounding is intended for medications that will be administered either through an IV or an injection.

What is the regional market scenario of the sterile compounding pharmacies market?

Global sterile compounding pharmacies market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for sterile compounding pharmacies market. The US is estimated to hold the largest share in the sterile compounding pharmacies market during the forecast period. The presence of top players and favorable regulations related to product approvals coupled with commercializing new products are the contributing factors for the regional growth. Additionally, the increasing number of R&D activities is the key factor responsible for the Asia-Pacific regional growth for sterile compounding pharmacies accounting fastest growth of the region during the coming years.

Who are the key players in the sterile compounding pharmacies market?

Fagron, Inc., Triangle Compounding Pharmacy, B. Braun Melsungen AG, PharMedium Healthcare Holdings, Inc., Fresenious Kabi AG, Avella Specialty Pharmacy, Pencol Compounding Pharmacy, Pavilion Compounding Pharmacy, LLC., Pace Pharmacy, and SandsRx are among the leading companies operating in the global sterile compounding pharmacies market

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - sterile compounding pharmacies market

  1. Fagron, Inc.
  2. Triangle Compounding Pharmacy
  3. B. Braun Melsungen AG
  4. PharMedium Healthcare Holdings, Inc.
  5. Fresenious Kabi AG
  6. Avella Specialty Pharmacy
  7. Pencol Compounding Pharmacy
  8. Pavilion Compounding Pharmacy, LLC.
  9. Pace Pharmacy
  10. SandsRx                                    

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.